Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
about
Colorectal cancer diagnosis: Pitfalls and opportunitiesAdjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysisSurveillance and Survivorship after Treatment for Colon CancerInter-individual variation in DNA repair capacity: a need for multi-pathway functional assays to promote translational DNA repair researchImpact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database.The prognostic value of simultaneous tumor and serum RAS/RAF mutations in localized colon cancer.Ten-year outcomes of a randomised trial of laparoscopic versus open surgery for colon cancer.Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for RecurrenceThe Repurposing Drugs in Oncology (ReDO) Project.Single-molecule quantification of 5-hydroxymethylcytosine for diagnosis of blood and colon cancers.The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort studyS-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial).Evaluation of the duplication of staging CT scans for localized colon cancer in a Medicare population.A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancerMicrosatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer.Optimal delivery of colorectal cancer follow-up care: improving patient outcomes.Low-dose capecitabine adjuvant chemotherapy in elderly stage II/III colorectal cancer patients (LC-ACEC): study protocol for a randomized controlled trial.Chemotherapy for Stage II Colon Cancer.Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.Adjuvant chemotherapy for colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO.Prognostic and Predictive Model for Stage II Colon Cancer Patients With Nonemergent Surgery: Who Should Receive Adjuvant Chemotherapy?Diagnostic value of dynamic contrast-enhanced magnetic resonance imaging in rectal cancer and its correlation with tumor differentiation.The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter StudyDiffusion-weighted whole-body imaging with background body signal suppression/T2-weighted image fusion of gastrointestinal cancersPrognostic and predictive value of extended RAS mutation and mismatch repair status in stage III colorectal cancerThe prognostic yield of biomarkers harvested in chemotherapy-naive stage II colon cancer: can we separate the wheat from the chaff?TNM-O: ontology support for staging of malignant tumours.The Radical Extent of lymphadenectomy - D2 dissection versus complete mesocolic excision of LAparoscopic Right Colectomy for right-sided colon cancer (RELARC) trial: study protocol for a randomized controlled trialClinically Meaningful Use of Blood Tumor Markers in Oncology.Comparative clinicopathological characteristics of colon and rectal T1 carcinomaPatient gender as a factor associated with lymph node metastasis in T1 colorectal cancer: A systematic review and meta-analysis.Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study.Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis.Finding the evidence for pulmonary metastasectomy in colorectal cancer: the PulMicc trial.The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancer.Practice parameters for early rectal cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines.COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer.How and when adjuvant treatment should be intensified in stage III colorectal cancers?Atypical presentation of sigmoid carcinoma.Garcinol exhibits anti-proliferative activities by targeting microsomal prostaglandin E synthase-1 in human colon cancer cells.
P2860
Q26774105-672EAC5A-4DE6-4488-A8BE-48A066CEAC59Q26774704-DC6634D6-731D-4059-A2A9-8F8500BAFAB6Q28088348-A39CA546-5027-41D3-BC8C-442F170B277FQ28388726-96CB12B9-8B2B-4E44-A488-2C91F9FCBBA8Q30315675-E08DC5D9-20BB-40CF-895B-B1EE123202A2Q33679614-AB59DAE4-0D52-473A-BCF2-D5F867B61E80Q33725934-5958E064-6521-409D-82A4-A519D300FEF1Q33749725-8220E4D1-7236-4BC9-A7AF-68F58C1901E1Q33893949-A934A578-7733-43ED-A8C6-9521BAD20D9AQ33908678-64F28E22-D655-494C-A848-71EB00AD744FQ33908938-161B5648-214B-4F82-927D-277CE14C708BQ34083135-DC6FADF9-716F-476B-8E17-924DC68859C9Q34339066-C23CA6E3-C539-42BA-8CCF-1488984C822CQ34995307-41BB7386-5D36-4971-AB93-01ABC8A0F536Q35191237-3F4BEC54-400D-41B0-B41A-22F16337FF69Q35654007-0F87D672-BBF6-4728-BAD4-73DCFF93E5C7Q35733020-301ABC7B-DA9D-48C7-B90C-C99E25984E7EQ36304759-650F23B2-0B67-4694-8292-2B66A6C823E1Q36406741-3EF6BF6A-0428-43F4-AB12-A50C66925641Q36429095-A0DCED17-A8BA-4826-BA52-439E48082E7BQ36444990-37B30077-F054-4B9D-B332-9828183686BBQ36741067-B9FBAC35-0EC1-4BB3-9C0D-CEB52E80A393Q36884441-E210C74B-3679-4CF4-A431-A7924C7F8F39Q37001771-F1F4CAB9-4F94-48F7-B8D0-1BA347405A52Q37098312-13353F92-4A70-4B83-9C92-3417A78C2722Q37256316-36719C40-B4B2-4269-A335-7DDE74C47D60Q37414684-6EBEE2C8-CB5A-4BFC-8BF8-3654EBF4587EQ37487724-4C407AC0-6AED-4B8B-A534-7E034DFEBA5DQ37500722-7C7B6168-DE1C-49C2-895B-64A0AAAF0E4DQ37701259-2159D2B9-D99A-41BC-850F-642B0869B539Q37731972-2C474E23-9C7B-49B6-BF95-3FA10049BBE0Q38194452-580CD26A-4F91-4BB1-A9BE-F629C400477DQ38269844-711EC2E8-A7EF-4B6E-A51E-F1D513D6895BQ38348082-4739F138-1E2C-40B3-8476-BA5D6AAE5D75Q38587521-2532027A-64AE-4FEA-B6F0-3C4E1D539F05Q38593140-EE2FC926-6C14-4B43-A371-341383E3C0DAQ38625517-485F3BCE-93C8-43D2-BA23-673646BC489FQ38638844-144FDEDB-E02B-4239-86D1-F1C6B5AB2C56Q38735148-8CDE16A8-6F5C-426F-9ACB-845F460CCA6FQ38754376-AA1E2948-5F03-4655-8A66-82D5D77FA14A
P2860
Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Early colon cancer: ESMO Clini ...... osis, treatment and follow-up.
@ast
Early colon cancer: ESMO Clini ...... osis, treatment and follow-up.
@en
Early colon cancer: ESMO Clini ...... osis, treatment and follow-up.
@nl
type
label
Early colon cancer: ESMO Clini ...... osis, treatment and follow-up.
@ast
Early colon cancer: ESMO Clini ...... osis, treatment and follow-up.
@en
Early colon cancer: ESMO Clini ...... osis, treatment and follow-up.
@nl
prefLabel
Early colon cancer: ESMO Clini ...... osis, treatment and follow-up.
@ast
Early colon cancer: ESMO Clini ...... osis, treatment and follow-up.
@en
Early colon cancer: ESMO Clini ...... osis, treatment and follow-up.
@nl
P2093
P2860
P356
P1433
P1476
Early colon cancer: ESMO Clini ...... nosis, treatment and follow-up
@en
P2093
A Cervantes
B Nordlinger
ESMO Guidelines Working Group
G D Beretta
P2860
P304
P356
10.1093/ANNONC/MDT354
P478
24 Suppl 6
P577
2013-10-01T00:00:00Z